This study evaluated the Autonomous Blood Drawing Optimization and Performance Testing (ADOPT) trial, which assessed the performance, safety, and patient experience of an autonomous robotic phlebotomy device (ARPD) utilizing multimodal imaging. The results demonstrated analytical equivalence to manual phlebotomy, a 94.5 percent first-stick success rate, and a low rate of mild adverse events (0.6 percent). The authors conclude that the ARPD is a safe and effective tool that may improve patient experience and address workforce challenges in phlebotomy.
You are here:
Performance, Safety, and Patient Experience of an Autonomous Robotic Phlebotomy Device: A Multicenter Trial
Submitted by: Joel Dunning
Source: Clinical Chemistry
Keywords:
Author(s): Luuk F. P. Giesen, Jeroen A. Roest, Frederique M. A. Koopman, Martine M. L. Deckers, Helena Chon, Christian M. Hackeng, Jurgen A. Riedl, Michiel de Bruin, Brooke M. Katzman, Warry van Gelder, Janne Cadamuro, Mads Nybo, Michael A. Fouraux, Thijs C. van Holten, Robert de Jonge
